StockStory.org on MSN41 分钟
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) in Q4 CY2024 as sales rose 4.7% year on year to $186.5 million.